-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the Supervisory Board of Royal DSM, a global science company focused on nutrition, health and green living, announced that the current Global Chief Executive Officer, Feike Sijbesma, is ending his term, and board members Geraldine Matchett and Fried Mr.
Dimitri de Vree\ze will serve as Co-CEO
.
Xie Baiman: leading the transformation of DSM for more than ten years
Xie Baiman: leading the transformation of DSM for more than ten yearsAfter 20 years on the board and nearly 13 years as global chief executive, Schieberman is stepping down as global chief executive officer and handing over to the company's leadership, and will seek personal development in other areas in the future
.
The current global CEO Mr.
Feike Sijbesma
Under Schieberman's leadership, DSM has achieved a major transformation - from a commodity chemicals company to a science company focused on nutrition, health and green living, with cumulative shareholder returns of up to 400%
.
Schieberman said: “It is a great honor to serve DSM for so many years.
I
would like to express my sincere thanks to the DSM Board of Directors, all colleagues and business partners for their close cooperation, as well as their great investment and contributions
.
Rob Routs, Chairman of the Supervisory Board, said on behalf of all DSM members: "We are very grateful for Schieberman's 32 years of service to DSM, especially his 13 years as Global Chief Executive Officer
.
Ma Jielan and Frederick: leading DSM to move forward
Ma Jielan and Frederick: leading DSM to move forwardAfter a comprehensive process evaluation and external benchmarking consideration, combined with the opinions of an international talent consulting firm, the DSM Supervisory Board decided to appoint two senior executives, Ma Jielan and Frederick Fried, as the group's co-CEOs
.
Ms.
Geraldine Matchett, current board member
Current Board Member Mr.
Dimitri de Vree\ze
As co-CEO, Ma Jielan will focus on financial management, capital market communication, capital allocation, talent training and cultural development, digital strategy and innovative ways of working
.
Over the years, Jielan Ma and Friede have demonstrated extraordinary leadership in working with Schieberman to shape the business
.
Ma Jielan joined DSM in 2014 as Chief Financial Officer and a member of the Board of Directors
.
Fried joined DSM in 1990 and has held various positions within the group, having been a board member since 2013
.
To ensure a smooth adaptation of DSM to the co-CEO leadership structure, the Supervisory Board will appoint Rob Routs as Chairman of the Supervisory Board for a final two-year term at the Annual General Meeting in May 2020
.
Ma Jielan and Friede said: "We are honored to be able to contribute to the future development of DSM
.
As co-CEOs, we will fully leverage our complementary strengths to continue DSM's success story and create a better life for all.
.
We will continue to lead DSM as an innovative scientific company, continue to adhere to sustainable development and forge ahead
.
We firmly believe that our close cooperation can lead to the continued success of the company
.
Schieberman has shown excellent leadership We will build on the solid foundation he has created to further advance the company's development
.
"
Rob Routs, Chairman of the Supervisory Board, said: "After thorough and careful consideration, we have come to the conclusion that the best candidate for succession lies within the company
.
Previously, Ma Jielan and Friede worked together with Xie Baiman to effectively promote business transformation and success through efficient collaboration.
development, creating great value for all stakeholders
.
The Supervisory Board has witnessed their joint efforts and believes that the co-CEO mechanism can drive the future development of DSM, achieve profitable growth and fulfill its commitment as an innovative scientific company , and create a positive impact on the world
.
Both Ma Jielan and Friede have deep industry knowledge and rich work experience, and they will continue to cooperate sincerely to ensure that DSM remains in the leading position in the industry
.
Given that Ma Jielan and Friede and Xie Baiman have already Having worked closely for many years and co-defined DSM's current growth strategy, I am confident that the transition will be smooth and I look forward to continuing to work with them
.
"
Mr.
Feike Sijbesma (centre), current global chief executive officer, with board members Ms.
Geraldine Matchett (left) and Mr.
Frederick (Dimitri de Vree\ze; right)
Mr.
Feike Sijbesma (centre), current global chief executive officer, with board members Ms.
Geraldine Matchett (left) and Mr.
Frederick (Dimitri de Vree\ze; right)
